期刊
CURRENT OPINION IN CELL BIOLOGY
卷 23, 期 6, 页码 744-755出版社
CURRENT BIOLOGY LTD
DOI: 10.1016/j.ceb.2011.09.003
关键词
-
类别
资金
- Canton of Basel
- Swiss Cancer League
- Louis-Jeantet Foundation
- Swiss National Science Foundation
The target of rapamycin (TOR) is a highly conserved serine/threonine kinase and a central controller of cell growth, metabolism and aging. Mammalian TOR (mTOR) is activated in response to nutrients, growth factors and cellular energy. Dysregulated mTOR signaling has been implicated in major disease. Here we review recent findings on the role of mTOR in cancer, metabolic disorders, neurological diseases, and inflammation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据